Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Study Type: Interventional
Official Title: Single Patient Treatment Protocol of TRC105 Combined With Standard-dose Bevacizumab for a Single Patient With Metastatic And Refractory Choriocarcinoma
Brief Summary: The purpose of this study is to determine whether TRC105 in combination with Bevacizumab is effective in the treatment of one patient with metastatic and refractory choriocarcinoma.